New 99.9% effective HIV injection launches in Africa
A groundbreaking twice-yearly HIV-prevention injection with over 99.9% efficacy begins rollout in Southern Africa, offering new hope in the fight against the virus. Read the full story.
A groundbreaking twice-yearly HIV-prevention injection with over 99.9% efficacy begins rollout in Southern Africa, offering new hope in the fight against the virus. Read the full story.
South Africa, Zambia, and Eswatini start administering the groundbreaking lenacapavir injection, offering 99.9% protection with just two shots a year. A major step in the fight against HIV/AIDS.
WHO urges African leaders to safeguard HIV progress as funding disruptions threaten decades of gains. New tools like Lenacapavir offer hope for transforming prevention efforts across the continent.